Absent pulmonary valve syndrome
A rare congenital heart defect with a challenging prognosis.
Absent pulmonary valve syndrome (APVS) is a congenital heart defect in which the flaps of the pulmonary valve do not develop or are severely underdeveloped, leading to aneurysms of the pulmonary arteries and softening of the trachea and bronchi. It often occurs with other heart defects, most commonly ventricular septal defect and right ventricular outflow tract obstruction, and is sometimes considered a variant of Tetralogy of Fallot. The earliest known description is often attributed to Chevers in 1846.
- first reported by
- Chevers
- year first reported
- 1846
Lore & Background
Absent pulmonary valve syndrome (APVS) is characterized by the absence or severe underdevelopment of the pulmonary valve flaps, resulting in dilated pulmonary arteries and tracheobronchomalacia. The condition is frequently associated with other congenital heart defects, particularly ventricular septal defect and right ventricular outflow tract obstruction, and is sometimes classified as a variant of Tetralogy of Fallot. The earliest known description is often attributed to Chevers in 1846.
Symptoms include respiratory distress and variable cyanosis, though rare asymptomatic cases occur. The syndrome has been linked to several congenital cardiac syndromes, including agenesis of ductus arteriosus, persistent ductus arteriosus, atrioventricular septal defect, and transposition of the great arteries. The most common chromosomal abnormality in APVS is a 22q11.2 deletion, found in 30–50% or more of cases.
Respiratory distress in newborns is common, often caused by compression of the bronchi by dilated pulmonary arteries, which can lead to massive lobar emphysema. The orientation of the infundibulum influences which pulmonary artery dilates: a right-oriented infundibulum causes aneurysmal dilation of the right pulmonary artery, compressing the middle lobe bronchus, while a left-oriented infundibulum affects the left pulmonary artery, compressing the left main and upper lobe bronchus.
Reader's Guide
Absent pulmonary valve syndrome is a significant congenital heart defect due to its poor prognosis and the complex interplay between cardiac and respiratory complications. The majority of newborns experience respiratory distress from bronchial compression caused by aneurysmal pulmonary arteries, often leading to massive lobar emphysema. The condition's association with chromosomal abnormalities, including 22q11 microdeletion in about 25% of cases, underscores its genetic underpinnings. As a variant of Tetralogy of Fallot, APVS highlights the spectrum of conotruncal heart defects. Its first description in 1830 by Crampton marks an early recognition of a rare anomaly. The syndrome's legacy lies in its challenging management, requiring surgical intervention to address both cardiac defects and airway obstruction, as reflected in the surgical literature from institutions such as The Royal Children's Hospital Melbourne.
Did You Know?
- The earliest known description of absent pulmonary valve syndrome is often attributed to Chevers in 1846.
- A 22q11.2 deletion is found in 30–50% or more of cases.
- The orientation of the infundibulum determines which pulmonary artery dilates aneurysmally.
- Massive lobar emphysema can result from bronchial compression by dilated pulmonary arteries.
Anatomical Definition & Historical Context
Absent pulmonary valve syndrome is a congenital cardiac malformation in which the leaflets of the pulmonary valve either fail to form at all or remain profoundly underdeveloped, a state termed hypoplasia. The absence of functional valve tissue leaves the downstream pulmonary arteries vulnerable to progressive dilation, producing aneurysmal changes. Beyond the vascular consequences, the surrounding airway structures—the trachea and bronchi—undergo a softening process known as tracheobronchomalacia, which further compromises respiratory function. In the vast majority of presentations, APVS does not appear in isolation; it is accompanied by additional structural heart anomalies, with ventricular septal defect and right ventricular outflow tract obstruction being the most frequent partners. Because of this clustering, clinicians often classify the condition as a morphological variant of Tetralogy of Fallot. The earliest documented observation of this syndrome dates back to 1830, when Crampton described the first recognized case, marking the beginning of nearly two centuries of clinical and surgical study into this rare and complex developmental disorder.
Clinical Presentation & Respiratory Manifestations
Patients with absent pulmonary valve syndrome most commonly present with respiratory distress and a degree of cyanosis that can fluctuate over time. In uncommon instances, however, affected individuals may appear entirely asymptomatic, making diagnosis particularly challenging without imaging. The respiratory compromise in APVS is not merely a secondary effect of poor cardiac output; it is driven by a direct mechanical problem. As the pulmonary arteries progressively dilate into aneurysmal structures, they press against the adjacent bronchial tree. This external compression can lead to massive lobar emphysema, a condition in which air becomes trapped behind the obstructed airway, further worsening the patient's breathing difficulty. The interplay between the dilated vasculature and the already-softened tracheobronchial walls—a consequence of the tracheobronchomalacia inherent to the syndrome—creates a vicious cycle of obstruction and air-trapping that defines the day-to-day clinical picture for most affected newborns and infants.
Genetic & Developmental Associations
Although the most frequently encountered form of absent pulmonary valve syndrome is the Tetralogy of Fallot variant, the condition has been documented in association with a wide spectrum of other congenital cardiac anomalies. Case literature links APVS to agenesis of the ductus arteriosus, persistent ductus arteriosus, atrioventricular septal defect, abnormal pulmonary branching patterns, transposition of the great arteries, and type B interrupted aortic arch. This breadth of associations underscores that the underlying developmental disruption is not confined to a single pathway. Chromosomal and microdeletion findings add another layer of complexity. Roughly one-quarter of identified cases carry chromosomal abnormalities, including deletions on chromosomes 6 and 7, Trisomy 13, and Trisomy 21. A separate quarter of cases has been associated with a 22q11 microdeletion. Taken together, these findings indicate that a substantial minority of APVS cases carry identifiable chromosomal or microdeletion abnormalities, broadening the diagnostic workup well beyond purely structural cardiac assessment.
Prognosis & the Role of Infundibular Geometry
The overall prognosis for absent pulmonary valve syndrome is poor, with the majority of affected newborns facing significant respiratory distress in addition to their cardiac pathology. A critical mechanical factor that shapes both the severity of symptoms and the pattern of vascular damage is the orientation of the pulmonary infundibulum. In most hearts this structure is vertically aligned and relatively short. In APVS, however, the infundibulum's direction determines which pulmonary artery will preferentially undergo aneurysmal dilation. When it is oriented horizontally and directed to the right, the right pulmonary artery experiences the most dramatic enlargement, pressing against and compressing the middle lobe bronchus. Conversely, a leftward horizontal orientation channels the aneurysmal growth into the left pulmonary artery, which then impinges on the left main bronchus and the upper lobe bronchus. This geometric relationship helps explain why the pattern of airway obstruction differs between patients and why the specific infundibular configuration is a critical factor in understanding each individual's disease course.
Frequently Asked Questions
Who is Absent pulmonary valve syndrome?
Absent pulmonary valve syndrome is a rare congenital heart defect in which the pulmonary valve leaflets fail to form or are severely underdeveloped. Rather than a character or entity, it is a structural condition present from birth that disrupts normal blood flow through the right side of the heart.
What are Absent pulmonary valve syndrome's powers/role?
Its effect on the body is essentially progressive damage: the malformed valve allows the pulmonary arteries to balloon into aneurysms while simultaneously softening the cartilage of the trachea and bronchi. It frequently co-occurs with a ventricular septal defect or right ventricular outflow tract obstruction, and some clinicians classify it as a variant of Tetralogy of Fallot.
How does Absent pulmonary valve syndrome's story end?
The prognosis is challenging because the expanding arterial aneurysms and airway compression can produce serious respiratory and circulatory complications over time. Survival and quality of life hinge on how early the defect is identified and how successfully surgical repair addresses both the valve and the associated outflow tract issues.
Why is Absent pulmonary valve syndrome important?
It is important because, despite its rarity, it carries high morbidity and demands coordinated multidisciplinary care involving cardiac surgery and airway management. Its overlap with Tetralogy of Fallot and other outflow tract anomalies also shapes how clinicians think about an entire family of congenital heart defects.
When was Absent pulmonary valve syndrome first discovered?
The earliest known description of the condition is credited to Chevers in 1846. That places its recognition more than a century and a half back in the medical literature, making it one of the longer-documented congenital heart anomalies.
More in Rare diseases 1-24
Spotted an error? Know more?
This is a living reference — every entry is fact-audited, and reader corrections feed straight into our audit queue. Suggest an edit · See this site's audit record
